This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1994 Apr 6;271(13):1023-4.

Tacrine for Alzheimer's disease. Which patient, what dose?

PMID: 8139061

Editorial

Tacrine for Alzheimer's disease. Which patient, what dose?

M A Winker. JAMA. 1994.

. 1994 Apr 6;271(13):1023-4.

Author

PMID: 8139061

No abstract available

PubMed Disclaimer

Comment on

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.
Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI. Knapp MJ, et al. JAMA. 1994 Apr 6;271(13):985-91. JAMA. 1994. PMID: 8139083 Clinical Trial.
Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease.
Watkins PB, Zimmerman HJ, Knapp MJ, Gracon SI, Lewis KW. Watkins PB, et al. JAMA. 1994 Apr 6;271(13):992-8. JAMA. 1994. PMID: 8139084 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information